Literature DB >> 22569358

Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice.

Mervi Kuronen1, Anna-Elina Lehesjoki, Anu Jalanko, Jonathan D Cooper, Outi Kopra.   

Abstract

The neuronal ceroid lipofuscinoses constitute the most common group of childhood neurodegenerative disorders. These devastating disorders still remain without effective treatment. The use of animal models has provided significant information about NCL pathogenesis, highlighting early glial activation and neuron loss in specific brain regions of affected animals. Here, we have characterized the timing and regional-specificity of the pathological events of CLN8 disease utilizing the Cln8 deficient mouse model, Cln8(mnd). We have studied the progression of neuron loss, astrocytosis and microglial activation from early to moderately symptomatic (1, 3 and 5 months) and late symptomatic (8 months) mice. In Cln8 deficiency, the somatosensory pathway comprising the thalamic ventral posterior nucleus (VPM/VPL) and the primary somatosensory cortex (S1BF) was found to be the most affected relay system. Scattered microglia that appeared partially activated were already present at 3 months of age, followed by astrocytosis and the loss of thalamic relay neurons at 5 months of age, with all these phenotypes and glial activation becoming more pronounced with disease progression. Reactive changes followed a similar pattern in the corresponding cortical target regions, but only moderate neuron loss was detected. Compared to the somatosensory system, in the visual thalamocortical pathway, neuron loss appeared relatively late in the disease, at 8 months. Neuron loss was preceded by glial activation in the dorsal lateral geniculate nucleus (LGNd) and in the primary visual cortex (V1). Taken together these data highlight the pathological targeting of the somatosensory thalamocortical pathway in Cln8 deficiency, in common with other forms of NCL. However, in contrast to other previously characterized NCL models, the Cln8(mnd) mouse shows relatively mild and late appearing pathology within the thalamocortical visual pathway.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569358     DOI: 10.1016/j.nbd.2012.04.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  14 in total

Review 1.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 2.  Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.

Authors:  Konrad Kaminiów; Sylwia Kozak; Justyna Paprocka
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

3.  Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene.

Authors:  Dolan Sondhi; Emma C Scott; Alvin Chen; Neil R Hackett; Andrew M S Wong; Agnieszka Kubiak; Hemanth R Nelvagal; Yewande Pearse; Susan L Cotman; Jonathan D Cooper; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2014-03-04       Impact factor: 5.695

Review 4.  Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses.

Authors:  Keigo Takahashi; Hemanth R Nelvagal; Jenny Lange; Jonathan D Cooper
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

5.  Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice.

Authors:  Yoshinori Tanaka; James K Chambers; Takashi Matsuwaki; Keitaro Yamanouchi; Masugi Nishihara
Journal:  Acta Neuropathol Commun       Date:  2014-07-15       Impact factor: 7.801

6.  Commentary: Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice.

Authors:  Timothy J Sargeant
Journal:  Front Aging Neurosci       Date:  2016-02-03       Impact factor: 5.750

7.  Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice.

Authors:  Tea Blom; Mia-Lisa Schmiedt; Andrew M Wong; Aija Kyttälä; Jarkko Soronen; Matti Jauhiainen; Jaana Tyynelä; Jonathan D Cooper; Anu Jalanko
Journal:  Dis Model Mech       Date:  2012-10-12       Impact factor: 5.758

8.  A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.

Authors:  Jeremy P Morgan; Helen Magee; Andrew Wong; Tarah Nelson; Bettina Koch; Jonathan D Cooper; Jill M Weimer
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

9.  Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV.

Authors:  Yulia Grishchuk; Sarmi Sri; Nikita Rudinskiy; Weiyuan Ma; Katherine G Stember; Matthew W Cottle; Ellen Sapp; Marian Difiglia; Alona Muzikansky; Rebecca A Betensky; Andrew M S Wong; Brian J Bacskai; Bradley T Hyman; Raymond J Kelleher; Jonathan D Cooper; Susan A Slaugenhaupt
Journal:  Acta Neuropathol Commun       Date:  2014-09-09       Impact factor: 7.801

10.  AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.

Authors:  Tyler B Johnson; Katherine A White; Jon J Brudvig; Jacob T Cain; Logan Langin; Melissa A Pratt; Clarissa D Booth; Derek J Timm; Samantha S Davis; Brandon Meyerink; Shibi Likhite; Kathrin Meyer; Jill M Weimer
Journal:  Mol Ther       Date:  2020-09-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.